Rabat: FM6SS has announced a significant breakthrough in the field of biotechnology with the successful reprogramming of blood cells into induced pluripotent stem (iPS) cells. This strategic advance is expected to pave the way for establishing a national platform for cell reprogramming and differentiation, which will benefit biomedical research, personalized medicine, and innovative therapies.
According to Agence Marocaine De Presse, the Foundation stated in a press release that this achievement highlights its commitment to transforming Morocco into a center of excellence in medical research and innovation, addressing major public health challenges. The director of the Mohammed VI Center for Research and Innovation emphasized the importance of this development in the Foundation’s mission.
iPS cells, which can be derived from a simple blood sample, possess two crucial properties: they can differentiate into any cell type in the body and have the capacity to multiply indefinitely. These characteristics make i
PS cells a revolutionary tool for modeling human diseases, testing the efficacy and safety of new drugs, developing regenerative therapies to repair vital tissues, and designing new immunotherapy approaches to cancer.
Internationally, iPS cells are already being explored in promising clinical trials aimed at treating degenerative diseases, retinal disorders, and certain blood disorders. Through this achievement, currently in the validation and scientific characterization phase, the Foundation is positioning Morocco as a pioneer in biotechnology and regenerative medicine.